NOTICE OF ANNUAL SHAREHOLDERS MEETING & PROXY INFORMATION

Company

TherapeuticsMD, Inc.

Filed

April 1, 2003

Period of Report

December 16, 2002

Accession Number

0000025743-03-000003

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →